GLP-1 Sulfur Burps, Bloating, and Gas: Why They Happen and What the Data Shows

It tastes like a boiled egg you never ate. For a lot of people starting semaglutide or tirzepatide, the sulfur burp is the side effect nobody warned them about.

Nausea gets the headlines in GLP-1 trials. Belching, bloating, and gas sit lower in the adverse event tables, often at single-digit percentages, which makes them easy to overlook. They are still among the most searched GLP-1 complaints, and they tend to arrive at a predictable time: the first days after a new dose.

This article covers how often these symptoms happen in the label data, the chemistry behind the rotten egg smell, why dose increases matter more than the dose itself, and the point where bloating stops being a nuisance and becomes a reason to call a doctor.

How common are burping, bloating, and gas on GLP-1 medicines?

Single digits, but real

Burping, bloating, and gas each affect roughly 5 to 9 percent of people on semaglutide 2.4 mg in the obesity trials, and only belching shows a large gap over placebo. The Wegovy US prescribing information lists dyspepsia at 9 percent versus 3 percent on placebo, eructation (belching) at 7 percent versus under 1 percent, abdominal distension at 7 percent versus 5 percent, flatulence at 6 percent versus 4 percent, and gastroesophageal reflux at 5 percent versus 3 percent.

The placebo column matters. Five percent of people on placebo also reported bloating, so a good share of the bloating people notice on a GLP-1 would have happened anyway. Belching is different: it barely appears in the placebo group, which makes it one of the more specific drug effects in the table. Tirzepatide labels show the same shape, with belching, dyspepsia, and reflux all more frequent on drug than placebo and rising slightly at higher doses.

Why do GLP-1 medicines cause sulfur burps?

Slow stomach, busy bacteria

GLP-1 medicines cause sulfur burps mainly by slowing gastric emptying, which keeps food in the stomach and small intestine longer and gives bacteria time to produce hydrogen sulfide. Hydrogen sulfide is the gas behind the rotten egg smell. Bacteria make it by breaking down the sulfur-containing amino acids cysteine and methionine, plus dietary sulfate, all of which are concentrated in protein foods.

The stomach is normally a fairly hostile place for bacteria because of its acidity. When a meal sits there for hours, and when slower transit lets more bacteria colonise the upper small intestine, fermentation can happen closer to the mouth than usual. Swallowed air and carbon dioxide from digestion then carry the sulfur smell back up as a belch.

Higher protein intake adds to the effect. People on a GLP-1 protocol are often told to prioritise protein to protect lean mass, which is sound advice, but a large whey shake or a plate of eggs on a slow stomach supplies exactly the substrate sulfur-producing bacteria use. The protein article on this site covers targets; the fix here is usually spacing, not cutting.

How long do sulfur burps and bloating last on a GLP-1?

Days, then weeks of adaptation

Sulfur burps and bloating on a GLP-1 usually peak in the 1 to 3 days after an injection and are worst in the weeks after starting or increasing the dose. Semaglutide and tirzepatide reach peak blood levels roughly 1 to 3 days after a weekly injection, which matches when many people notice fullness and belching.

The longer-term picture is more encouraging. Halawi and colleagues (Lancet Gastroenterology and Hepatology, 2017) measured gastric emptying in people on liraglutide 3.0 mg and found the delay was greatest at 5 weeks and had shrunk, though not vanished, by 16 weeks. That fading effect, called tachyphylaxis, is why most digestive complaints settle at a steady dose. In STEP 1, the large majority of gastrointestinal events were mild to moderate and transient, and most occurred during the 16 week escalation.

Does a slower dose ramp reduce GLP-1 gas and bloating?

Plausible, not directly tested

A slower or lower dose ramp is likely to reduce GLP-1 gas and bloating, because digestive side effects in GLP-1 trials rise with dose and cluster after each step up. Dose-ranging work with semaglutide, including the phase 2 trial by O'Neil and colleagues (Lancet, 2018), found gastrointestinal events were more frequent at higher doses and with faster escalation. That relationship is the logic behind the standard 4 week steps in the label.

No trial has measured belching or bloating under microdose protocols, so the chart below is a hypothetical picture of the idea rather than data. The pattern it shows is the one prescribers aim for: smaller bumps after each increase, and a lower baseline in between. The gentle ramp article on this site goes into escalation schedules in more detail.

Why is GLP-1 gas so smelly, and why is there more of it?

Volume comes from carbs, odour from sulfur

Smelly gas on a GLP-1 comes mostly from hydrogen sulfide, while the amount of gas depends mostly on how much fermentable carbohydrate reaches the colon. Suarez, Springfield, and Levitt (Gut, 1998) analysed flatus from healthy volunteers and found sulfur gases, led by hydrogen sulfide, accounted for most of the odour judged by a panel. The bulk of flatus volume is odourless hydrogen, carbon dioxide, nitrogen, and in some people methane.

Diet changes volume dramatically. Tomlin, Lowis, and Read (Gut, 1991) measured flatus in healthy men and found about 214 mL a day on a fibre-free diet versus about 705 mL on a normal diet with 200 g of baked beans added. Many people on a GLP-1 increase fibre to manage constipation, often all at once. A sudden jump in beans, lentils, inulin, or sugar alcohols can raise gas output within days, so adding fibre in steps over 2 to 3 weeks tends to go better.

Which foods make sulfur burps worse on a GLP-1?

Sulfur load, fat, and portion size

Foods high in sulfur compounds, large fatty meals, and carbonated drinks are the usual triggers for sulfur burps on a GLP-1. Eggs, red meat, and whey protein are rich in sulfur amino acids. Broccoli, cabbage, cauliflower, garlic, and onions contain their own sulfur compounds. Dried fruit and some wines carry sulfites, and carbonated water adds gas directly to a stomach that is already slow to empty.

Fat slows gastric emptying on its own, so a high-fat meal on top of a GLP-1 doubles the brake. Portion size matters for the same reason. People who eat a normal-sized dinner out of habit, after a day of suppressed appetite, often describe the worst burps that evening or the next morning.

None of these foods need to be cut permanently. A food and symptom log over two injection cycles usually shows one or two clear culprits. Moving protein from one large meal into three or four smaller servings, and finishing eating 3 hours before lying down, covers most of the ground for most people.

What do people use to manage GLP-1 burping and bloating?

Small changes first, pharmacy second

Smaller meals, slower eating, fewer fizzy drinks, and a short walk after meals are the first steps most clinicians suggest for GLP-1 burping and bloating. None of these has been tested in a GLP-1 trial, but each targets a known contributor: stomach volume, swallowed air, and transit speed. Light walking after a meal speeds gas clearance in studies of people with bloating.

Over-the-counter products come up often in patient forums. Bismuth subsalicylate binds hydrogen sulfide and sharply cut hydrogen sulfide release in a 1998 Gastroenterology study by Suarez and colleagues, but it contains a salicylate and can darken the tongue and stool. Simethicone has weak and mixed evidence. Antacids or acid reducers may help reflux symptoms that overlap with belching. Any of these should be cleared with a pharmacist, particularly for people on blood thinners or with kidney disease, and none should be used to mask symptoms that are getting worse.

How many people stop GLP-1 treatment because of digestive side effects?

A small minority, but more than placebo

About 1 in 22 people in the STEP 1 trial stopped semaglutide 2.4 mg because of gastrointestinal adverse events. Wilding and colleagues (New England Journal of Medicine, 2021) reported 4.5 percent discontinuing for gastrointestinal reasons on semaglutide versus 0.8 percent on placebo, across 68 weeks. Nausea and vomiting drove most of those exits. Belching and bloating rarely end treatment alone, but they add to the overall burden, especially in people who already have reflux or irritable bowel symptoms.

When is bloating on a GLP-1 a warning sign?

Five symptoms that need a doctor, not an antacid

Bloating on a GLP-1 is a warning sign when it comes with severe pain, repeated vomiting, or signs that the bowel has stopped moving. GLP-1 prescribing information lists acute pancreatitis, gallbladder disease, and, in postmarketing reports, ileus as possible serious effects. The symptoms below need prompt medical assessment.

Frequently Asked Questions